Food Allergy Peanut
10
5
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (10)
Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
Pathway to Peanut Tolerance
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
Intervention to Reduce Early (Peanut) Allergy in Children
Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
EPAP, Interviewstudy
TRANS-FOODS: Preventing Peanut Allergy Through Improved Understanding of the Transcutaneous Sensitisation Route, Novel Food Processing and Skin Care Adaptations
Preventing Anaphylaxis With Acalabrutinib
Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy